These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 17913305

  • 1. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W, Wu W, Xu X.
    Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305
    [Abstract] [Full Text] [Related]

  • 2. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L, Liu K, Zhao W, Li X, Li T, Tang F, Zhang R, Wu W, Xi T.
    Appl Microbiol Biotechnol; 2013 Mar 01; 97(6):2367-78. PubMed ID: 23064457
    [Abstract] [Full Text] [Related]

  • 3. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
    Guo L, Li X, Tang F, He Y, Xing Y, Deng X, Xi T.
    Appl Microbiol Biotechnol; 2012 Mar 01; 93(5):1937-45. PubMed ID: 22134639
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T.
    Appl Microbiol Biotechnol; 2012 Sep 01; 95(6):1437-44. PubMed ID: 22569640
    [Abstract] [Full Text] [Related]

  • 5. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J, Dai LX, Pan X, Wang H, Li B, Zhu J, Li MY, Shi XL, Wang BN.
    Pathog Dis; 2015 Jul 01; 73(5):. PubMed ID: 25846576
    [Abstract] [Full Text] [Related]

  • 6. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X, Xing Y, Guo L, Lv X, Song H, Xi T.
    Pathog Dis; 2014 Oct 01; 72(1):78-86. PubMed ID: 24687988
    [Abstract] [Full Text] [Related]

  • 7. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X, Hu J, Zhang X, Fan D.
    Chin Med J (Engl); 2002 Oct 01; 115(10):1513-6. PubMed ID: 12490099
    [Abstract] [Full Text] [Related]

  • 8. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on H. pylori Infection in Mongolian gerbils.
    Guo L, Yang H, Tang F, Yin R, Liu H, Gong X, Wei J, Zhang Y, Xu G, Liu K.
    Front Cell Infect Microbiol; 2017 Oct 01; 7():349. PubMed ID: 28824883
    [Abstract] [Full Text] [Related]

  • 9. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
    Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y.
    Appl Microbiol Biotechnol; 2014 Apr 01; 98(8):3495-507. PubMed ID: 24370888
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y, Liu W, Li X, Guo L, Lv X, Xi T.
    Biochem Biophys Res Commun; 2015 Jul 03; 462(3):269-74. PubMed ID: 25957472
    [Abstract] [Full Text] [Related]

  • 11. Protection Against Helicobacter pylori Infection in BALB/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC.
    Pan X, Ke H, Niu X, Li S, Lv J, Pan L.
    Front Immunol; 2018 Jul 03; 9():1003. PubMed ID: 29867978
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, Mao XH, Guo G, Wu C, Zou QM.
    Vaccine; 2011 Sep 02; 29(38):6679-85. PubMed ID: 21745524
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL.
    Mol Cell Probes; 2014 Feb 02; 28(1):25-30. PubMed ID: 24036137
    [Abstract] [Full Text] [Related]

  • 14. [Preparation oral liposome-encapsulated recombinant Helicobacter pylori heat shock protein 60 vaccine for prevention of Hp infection].
    Huang W, Bai Y, Wang JD, Wu JB, Li GF, Zhang WM, Zhou DY.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May 02; 25(5):531-4. PubMed ID: 15897126
    [Abstract] [Full Text] [Related]

  • 15. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L, Breslin MB, Correa H, Bégué RE.
    Helicobacter; 2006 Dec 02; 11(6):517-22. PubMed ID: 17083372
    [Abstract] [Full Text] [Related]

  • 16. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B, Boris S, Isler P, Grangette C, Mercenier A.
    J Infect Dis; 2005 Oct 15; 192(8):1441-9. PubMed ID: 16170763
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.
    Helicobacter; 2006 Apr 15; 11(2):113-22. PubMed ID: 16579841
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, Lee A.
    FEMS Immunol Med Microbiol; 2007 Jul 15; 50(2):213-9. PubMed ID: 17567282
    [Abstract] [Full Text] [Related]

  • 19. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B, Pan X, Wang H, Zhou Y, Zhu J, Yang J, Li W.
    Int J Clin Exp Pathol; 2014 Jul 15; 7(10):6559-66. PubMed ID: 25400734
    [Abstract] [Full Text] [Related]

  • 20. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
    Lü L, Cao HD, Zeng HQ, Wang PL, Wang LJ, Liu SN, Xiang TX.
    Vaccine; 2009 Feb 11; 27(7):972-8. PubMed ID: 19111590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.